In their roles as Artrya US CEOs, the two will guide Artrya’s launch in the US, including the development of its US strategy, clinical research partnerships and go to market approach. Plans are progressing well with a significant medical group in the USA for retrospective clinical trials and a contract is expected within the coming weeks.
News: AYA Artrya Says It Opens U.S. Operations In Los Angeles, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AYA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.18M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14823 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 19029 | 2 |
View Market Depth
| Last trade - 12.30pm 23/08/2024 (20 minute delay) ? |
| AYA (ASX) Chart |
Day chart unavailable